Comparison of Therapeutic Lipid Target Achievements Among High-Risk Patients in Oman
2013; SAGE Publishing; Volume: 65; Issue: 5 Linguagem: Inglês
10.1177/0003319713482572
ISSN1940-1574
AutoresKhalid Al-Waili, Ibrahim Al‐Zakwani, Tamima Al-Dughaishi, Yajnavalka Baneerje, Hilal Al‐Sabti, Khamis Al-Hashmi, Hatem Farhan, Khadija Al Habsi, Ali T. Al‐Hinai, Khalid Al‐Rasadi,
Tópico(s)Pharmaceutical Practices and Patient Outcomes
ResumoWe compared therapeutic lipid target achievements among patients with diabetes or coronary heart disease (CHD) in Oman. A retrospective chart review of 94 patients was conducted at an outpatient clinic in Sultan Qaboos University Hospital, Muscat, Oman. The variables included low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and apolipoprotein B (apo B). The overall mean age of the cohort was 59 ± 12 years, 54% were male, 66% were diabetic, 48% hypertensive, 45% had CHD, 94% were on simvastatin, 4% were on fenofibrate, and 2% were on both simvastatin and fenofibrate. Lipid goal attainments of calculated LDL-C (<2.6 mmol/L), apo B (<0.9 g/L), and non-HDL-C (<3.36 mmol/L) were reached in 52%, 39%, and 53% of the patients, respectively. A significant proportion of high-risk patients treated with lipid-lowering agents reach LDL-C but not the apo B treatment targets, suggesting that the use of apo B target values should also be considered.
Referência(s)